Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.

Jänne PA, Simon GR, Langer CJ, Taub RN, Dowlati A, Fidias P, Monberg M, Obasaju C, Kindler H.

J Clin Oncol. 2008 Mar 20;26(9):1465-71. doi: 10.1200/JCO.2007.14.7611.

2.

Pemetrexed: a multitargeted antifolate.

Rollins KD, Lindley C.

Clin Ther. 2005 Sep;27(9):1343-82. Review.

PMID:
16291410
3.

Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma.

Green J, Dundar Y, Dodd S, Dickson R, Walley T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005574. Review.

PMID:
17253564
4.

Pemetrexed for diffuse malignant pleural mesothelioma.

Manegold C, Aisner J.

Semin Oncol. 2002 Apr;29(2 Suppl 5):30-5. Review.

PMID:
12023790
5.

[Malignant pleural mesothelioma].

Nishiwaki Y.

Gan To Kagaku Ryoho. 2003 May;30(5):589-94. Review. Japanese.

PMID:
12795087
6.

Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.

Suwanrusme H, Meyer ML, Green MR.

Clin Lung Cancer. 2004 Apr;5 Suppl 2:S56-60. Review.

PMID:
15117426
7.

Phase I trials of pemetrexed.

Fossella FV, Gatzemeier U.

Semin Oncol. 2002 Apr;29(2 Suppl 5):8-16. Review.

PMID:
12023787
8.

The pemetrexed/gemcitabine combination in pancreatic cancer.

Kindler HL.

Cancer. 2002 Aug 15;95(4 Suppl):928-32. Review.

9.

Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.

Manegold C.

Semin Oncol. 2003 Aug;30(4 Suppl 10):32-6. Review.

PMID:
12917819
10.

Pemetrexed in malignant pleural mesothelioma.

Gatzemeier U.

Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):26-31. Review.

11.

Pemetrexed in pancreatic cancer.

Seitz JF, Dahan L, Ries P.

Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):43-7. Review.

12.

The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.

Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

J Thorac Oncol. 2006 Jul;1(6):591-601. Review.

13.

Novel combinations using pemetrexed in malignant mesothelioma.

Gadgeel SM, Pass HI.

Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. Review.

PMID:
15117427
14.
15.

Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.

Budde LS, Hanna NH.

Expert Rev Anticancer Ther. 2004 Jun;4(3):361-8. Review.

PMID:
15161435
16.

Pemetrexed and malignant pleural mesothelioma.

Marangolo M, Vertogen B.

Ann Oncol. 2006 May;17 Suppl 5:v103-5. Review.

17.

The emerging role of antifolates in the treatment of malignant pleural mesothelioma.

Fizazi K, John WJ, Vogelzang NJ.

Semin Oncol. 2002 Feb;29(1):77-81. Review.

PMID:
11836672
18.
19.

Current chemotherapeutic treatment of malignant pleural mesothelioma.

Nowak AK, Byrne MJ, Millward MJ, Alvarez JM, Robinson BW.

Expert Opin Pharmacother. 2004 Dec;5(12):2441-9. Review.

PMID:
15571462
20.

An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.

Zilembo N, Vitali M, Pietrantonio F, Platania M, Del Vecchio M, Bajetta E.

Tumori. 2010 Nov-Dec;96(6):1031-4. Review.

Items per page

Supplemental Content

Write to the Help Desk